Considering that the high expression of HSF1 in various types of cancers are frequently associated with poor prognosis and resistance for chemotherapy [11], the sensitizing effects of KRIBB11 on the suppression of cancer cell growth appear to be a promising therapeutic strategy for clinical application. The gene discussed is HSF1; the disease is cancer.